Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Artery Obstruction | 19 | 2024 | 38 | 4.800 |
Why?
|
| Renal Circulation | 12 | 2024 | 48 | 2.990 |
Why?
|
| Kidney | 19 | 2020 | 1147 | 2.350 |
Why?
|
| Magnetic Resonance Imaging | 13 | 2024 | 3465 | 1.590 |
Why?
|
| Glomerular Filtration Rate | 8 | 2024 | 276 | 1.290 |
Why?
|
| Sus scrofa | 5 | 2024 | 51 | 1.040 |
Why?
|
| Disease Models, Animal | 16 | 2024 | 2384 | 1.040 |
Why?
|
| Hypertension, Renovascular | 6 | 2016 | 12 | 0.990 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2017 | 300 | 0.980 |
Why?
|
| Renal Artery | 4 | 2024 | 52 | 0.870 |
Why?
|
| Cerebrovascular Circulation | 1 | 2024 | 231 | 0.840 |
Why?
|
| Stents | 3 | 2024 | 409 | 0.830 |
Why?
|
| Natural Language Processing | 1 | 2023 | 38 | 0.830 |
Why?
|
| Adiposity | 4 | 2017 | 76 | 0.800 |
Why?
|
| Predictive Value of Tests | 3 | 2024 | 1727 | 0.800 |
Why?
|
| Glioblastoma | 1 | 2024 | 265 | 0.790 |
Why?
|
| Swine | 19 | 2017 | 588 | 0.790 |
Why?
|
| Radiation Oncology | 1 | 2023 | 121 | 0.750 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 3 | 2014 | 61 | 0.640 |
Why?
|
| Atherosclerosis | 4 | 2016 | 258 | 0.630 |
Why?
|
| Brain Neoplasms | 1 | 2024 | 785 | 0.620 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2024 | 688 | 0.580 |
Why?
|
| Fibrosis | 11 | 2020 | 234 | 0.570 |
Why?
|
| Oxygen Consumption | 4 | 2014 | 245 | 0.530 |
Why?
|
| Microcirculation | 6 | 2018 | 104 | 0.470 |
Why?
|
| Kidney Diseases | 2 | 2014 | 320 | 0.470 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2016 | 1254 | 0.460 |
Why?
|
| Angioplasty | 2 | 2014 | 70 | 0.460 |
Why?
|
| Cardio-Renal Syndrome | 1 | 2013 | 6 | 0.450 |
Why?
|
| Oxygen | 7 | 2024 | 743 | 0.440 |
Why?
|
| Animals | 28 | 2024 | 27476 | 0.430 |
Why?
|
| Endothelial Cells | 3 | 2014 | 462 | 0.430 |
Why?
|
| Metabolic Syndrome | 4 | 2018 | 123 | 0.430 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2016 | 331 | 0.410 |
Why?
|
| Kidney Tubules | 2 | 2012 | 92 | 0.410 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2013 | 164 | 0.410 |
Why?
|
| Kidney Medulla | 1 | 2012 | 80 | 0.390 |
Why?
|
| Microvessels | 5 | 2016 | 69 | 0.390 |
Why?
|
| Hypertension | 3 | 2015 | 745 | 0.360 |
Why?
|
| Furosemide | 3 | 2024 | 34 | 0.350 |
Why?
|
| Kidney Cortex | 2 | 2024 | 34 | 0.340 |
Why?
|
| Ventricular Function, Left | 1 | 2013 | 607 | 0.330 |
Why?
|
| Diuretics | 2 | 2024 | 75 | 0.320 |
Why?
|
| Angioplasty, Balloon | 2 | 2024 | 96 | 0.320 |
Why?
|
| Myocardium | 4 | 2016 | 572 | 0.310 |
Why?
|
| Cardiomyopathies | 3 | 2016 | 265 | 0.300 |
Why?
|
| Phantoms, Imaging | 1 | 2010 | 453 | 0.290 |
Why?
|
| Oxidative Stress | 10 | 2016 | 457 | 0.290 |
Why?
|
| Obesity | 4 | 2015 | 971 | 0.280 |
Why?
|
| Mitochondria, Heart | 3 | 2016 | 50 | 0.270 |
Why?
|
| Time Factors | 5 | 2024 | 5333 | 0.260 |
Why?
|
| Macrophages | 3 | 2013 | 578 | 0.250 |
Why?
|
| Hemodynamics | 6 | 2015 | 731 | 0.250 |
Why?
|
| Female | 18 | 2024 | 46371 | 0.250 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2012 | 888 | 0.250 |
Why?
|
| Elasticity Imaging Techniques | 2 | 2013 | 56 | 0.210 |
Why?
|
| Prognosis | 2 | 2024 | 3783 | 0.200 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2024 | 849 | 0.200 |
Why?
|
| Chemoradiotherapy | 1 | 2024 | 309 | 0.200 |
Why?
|
| Inflammation | 5 | 2013 | 975 | 0.200 |
Why?
|
| Autophagy | 2 | 2014 | 159 | 0.190 |
Why?
|
| Male | 9 | 2024 | 42464 | 0.180 |
Why?
|
| Acute Kidney Injury | 2 | 2014 | 316 | 0.170 |
Why?
|
| Collateral Circulation | 1 | 2018 | 37 | 0.160 |
Why?
|
| Renal Veins | 2 | 2014 | 28 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2018 | 405 | 0.140 |
Why?
|
| Aged | 5 | 2024 | 19144 | 0.140 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2016 | 47 | 0.140 |
Why?
|
| Cardiolipins | 1 | 2016 | 17 | 0.140 |
Why?
|
| Mice | 4 | 2020 | 11828 | 0.130 |
Why?
|
| Humans | 9 | 2024 | 89567 | 0.130 |
Why?
|
| Ultrasonic Therapy | 1 | 2016 | 37 | 0.130 |
Why?
|
| Apoptosis | 4 | 2016 | 1717 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2012 | 2666 | 0.120 |
Why?
|
| Endothelial Progenitor Cells | 1 | 2014 | 13 | 0.120 |
Why?
|
| Positron-Emission Tomography | 1 | 2016 | 337 | 0.120 |
Why?
|
| Movement | 1 | 2016 | 310 | 0.120 |
Why?
|
| Ischemia | 1 | 2016 | 252 | 0.120 |
Why?
|
| Middle Aged | 4 | 2024 | 25996 | 0.110 |
Why?
|
| Hypertrophy | 1 | 2013 | 67 | 0.110 |
Why?
|
| Adult | 4 | 2024 | 26684 | 0.110 |
Why?
|
| Mice, 129 Strain | 1 | 2013 | 56 | 0.110 |
Why?
|
| Coronary Stenosis | 1 | 2014 | 39 | 0.110 |
Why?
|
| Arginase | 1 | 2013 | 16 | 0.110 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2015 | 142 | 0.110 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2013 | 32 | 0.110 |
Why?
|
| Arterial Pressure | 1 | 2013 | 38 | 0.110 |
Why?
|
| Receptors, Angiotensin | 1 | 2013 | 12 | 0.110 |
Why?
|
| Perfusion Imaging | 1 | 2013 | 50 | 0.110 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2013 | 71 | 0.110 |
Why?
|
| Insulin Resistance | 2 | 2014 | 353 | 0.110 |
Why?
|
| Tetrazoles | 1 | 2013 | 24 | 0.110 |
Why?
|
| Atrophy | 1 | 2013 | 122 | 0.110 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2013 | 39 | 0.110 |
Why?
|
| Valine | 1 | 2013 | 62 | 0.110 |
Why?
|
| Computer Simulation | 1 | 2017 | 1101 | 0.110 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2013 | 60 | 0.110 |
Why?
|
| Treatment Outcome | 2 | 2024 | 8209 | 0.100 |
Why?
|
| Nephritis | 1 | 2012 | 17 | 0.100 |
Why?
|
| Oximetry | 1 | 2013 | 82 | 0.100 |
Why?
|
| Blood Volume | 1 | 2012 | 49 | 0.100 |
Why?
|
| Disease Progression | 2 | 2013 | 1463 | 0.100 |
Why?
|
| Proteinuria | 1 | 2012 | 67 | 0.100 |
Why?
|
| Health Status Indicators | 1 | 2012 | 103 | 0.100 |
Why?
|
| Antigens, CD | 1 | 2013 | 466 | 0.100 |
Why?
|
| Reproducibility of Results | 3 | 2016 | 2763 | 0.100 |
Why?
|
| Severity of Illness Index | 2 | 2014 | 1850 | 0.090 |
Why?
|
| Heart Rate | 1 | 2013 | 498 | 0.090 |
Why?
|
| Capillaries | 1 | 2011 | 90 | 0.090 |
Why?
|
| Myocytes, Cardiac | 1 | 2014 | 314 | 0.090 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2012 | 156 | 0.090 |
Why?
|
| Mitochondria | 1 | 2014 | 554 | 0.090 |
Why?
|
| Retrospective Studies | 1 | 2024 | 9112 | 0.090 |
Why?
|
| Reperfusion | 1 | 2010 | 31 | 0.090 |
Why?
|
| Peptides | 1 | 2014 | 649 | 0.090 |
Why?
|
| Regional Blood Flow | 1 | 2010 | 198 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2014 | 555 | 0.080 |
Why?
|
| Kidney Function Tests | 3 | 2014 | 115 | 0.080 |
Why?
|
| Neovascularization, Physiologic | 3 | 2014 | 143 | 0.070 |
Why?
|
| Blood Pressure | 3 | 2016 | 902 | 0.060 |
Why?
|
| Random Allocation | 2 | 2016 | 327 | 0.060 |
Why?
|
| Contrast Media | 1 | 2010 | 1084 | 0.060 |
Why?
|
| Algorithms | 1 | 2013 | 1896 | 0.060 |
Why?
|
| Oligopeptides | 2 | 2016 | 188 | 0.060 |
Why?
|
| Models, Biological | 1 | 2010 | 1762 | 0.050 |
Why?
|
| Inflammation Mediators | 2 | 2014 | 153 | 0.050 |
Why?
|
| Blood Flow Velocity | 1 | 2018 | 200 | 0.040 |
Why?
|
| tert-Butylhydroperoxide | 1 | 2016 | 2 | 0.030 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2016 | 25 | 0.030 |
Why?
|
| Mitochondrial Diseases | 1 | 2016 | 12 | 0.030 |
Why?
|
| Biomarkers | 2 | 2013 | 1768 | 0.030 |
Why?
|
| Vascular Remodeling | 1 | 2016 | 22 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2013 | 1668 | 0.030 |
Why?
|
| Multidetector Computed Tomography | 1 | 2016 | 59 | 0.030 |
Why?
|
| Lipoproteins, LDL | 1 | 2016 | 85 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2016 | 107 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2016 | 91 | 0.030 |
Why?
|
| Electron Transport | 1 | 2015 | 74 | 0.030 |
Why?
|
| Antioxidants | 1 | 2016 | 226 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2015 | 119 | 0.030 |
Why?
|
| Heart Function Tests | 1 | 2014 | 33 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2014 | 231 | 0.030 |
Why?
|
| Cholesterol | 1 | 2016 | 360 | 0.030 |
Why?
|
| Hyperlipidemias | 1 | 2014 | 92 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2016 | 275 | 0.030 |
Why?
|
| Coronary Circulation | 1 | 2014 | 131 | 0.030 |
Why?
|
| Valsartan | 1 | 2013 | 11 | 0.030 |
Why?
|
| Reference Values | 1 | 2014 | 661 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 642 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2013 | 49 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2013 | 171 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2014 | 899 | 0.030 |
Why?
|
| Acetylcholine | 1 | 2012 | 177 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2013 | 218 | 0.030 |
Why?
|
| Diet, Atherogenic | 1 | 2012 | 15 | 0.030 |
Why?
|
| Collagen | 1 | 2014 | 294 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2014 | 280 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 793 | 0.020 |
Why?
|
| Heart | 1 | 2014 | 574 | 0.020 |
Why?
|
| Triglycerides | 1 | 2011 | 233 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2013 | 260 | 0.020 |
Why?
|
| Hypoxia | 1 | 2016 | 654 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 1798 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1862 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 2884 | 0.020 |
Why?
|
| Cytokines | 1 | 2013 | 806 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 2015 | 0.020 |
Why?
|
| Diet | 1 | 2011 | 443 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 3237 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 4309 | 0.020 |
Why?
|
| Genotype | 1 | 2011 | 1853 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 2447 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 6766 | 0.010 |
Why?
|